

GLOW+ — BPC-157 | TB-500 | GHK-Cu | Thymosin Alpha-1 Peptide
Quad-peptide regeneration blend with BPC-157, GHK-Cu, TB-500 and Thymosin Alpha-1. Enhanced GLOW formula with immune-modulating Ta1 for tissue repair, skin rejuvenation and immune support research.
This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.
Quick Facts
| SKU | ACR-GLOWPLUS |
|---|---|
| CAS Number | 137525-51-0 / 49557-75-7 / 77591-33-4 / 62304-98-7 |
| Molecular Weight | BPC-157: 1419.54 Da | GHK-Cu: 403.96 Da | TB-500: 4963.44 Da | Ta1: 3108.28 Da |
| Sequence | BPC-157 + GHK-Cu + TB-500 + Thymosin Alpha-1 |
| Purity | >=99% |
| Physical Form | Lyophilized Powder |
| Storage | Store at -20°C |
What is GLOW+?
GLOW+ is an enhanced version of the GLOW blend, combining four synergistic research peptides: BPC-157 (tissue repair), TB-500 (cell migration), GHK-Cu (collagen synthesis), and Thymosin Alpha-1 (immune modulation). The addition of TA1 provides an immune-boosting dimension absent from the standard GLOW formula.
Synergistic Mechanisms
BPC-157: Angiogenesis via FAK-paxillin pathway. TB-500: Cell migration via actin polymerization. GHK-Cu: Collagen/elastin synthesis and antioxidant defense. Thymosin Alpha-1: TLR9-mediated dendritic cell activation, enhancing innate and adaptive immunity. The combination targets tissue repair, regeneration, and immune support simultaneously.
Frequently Asked Questions
What does GLOW+ contain vs GLOW?
GLOW = BPC-157 + TB-500 + GHK-Cu. GLOW+ adds Thymosin Alpha-1, providing immune modulation via TLR9 signaling and dendritic cell activation on top of the tissue repair foundation.
What sizes are available?
GLOW+ is available in 60mg and 75mg vials, with each component at research-grade purity (>=98% HPLC verified).
For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.


